Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2011 by Shandong Luye Pharmaceutical Co., Ltd..
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Shandong Luye Pharmaceutical Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01282619
First received: January 24, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)